PTOV1 antagonizes MED25 in RAR transcriptional activation

Hye-Sook Youn1, Ui-Hyun Park, Eun-Joo Kim

  • 1Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul 143-747, Republic of Korea.

Insights

Retinoic acid (RA) therapy resistance in cancer may involve MED25 and PTOV1 proteins. These proteins competitively bind to CBP, affecting RA receptor activity and cancer cell sensitivity to RA treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Retinoic acid (RA) is a crucial therapeutic agent in cancer treatment.
  • Acquired resistance limits the long-term efficacy of RA therapy, and its mechanisms remain incompletely understood.
  • MED25 enhances Retinoic Acid Receptor (RAR) transcriptional activity via association with CREB-binding protein (CBP).

Purpose of the Study:

  • To investigate the reciprocal regulation of RAR transcriptional activity by MED25 and prostate tumor over-expressed protein 1 (PTOV1).
  • To elucidate the molecular mechanisms underlying retinoic acid resistance in cancer therapy.
  • To determine how MED25 and PTOV1 expression levels influence cancer cell sensitivity to RA.

Main Methods:

  • Investigated competitive binding interactions between MED25, PTOV1, and CBP.
  • Analyzed the recruitment of CBP to RA-responsive gene promoters.
  • Assessed the modulation of RA sensitivity in cancer cells based on MED25 and PTOV1 expression levels.

Main Results:

  • MED25 and PTOV1 competitively bind to CBP, reciprocally regulating RAR transcriptional activity.
  • These proteins exert opposing effects on CBP recruitment to RA-responsive gene promoters.
  • Differential expression of MED25 and PTOV1 significantly modulates RA sensitivity in cancer cells.

Conclusions:

  • MED25 and PTOV1 play a critical role in regulating RA sensitivity through competitive binding to CBP.
  • Their opposing actions on CBP recruitment offer a potential molecular basis for acquired RA resistance during cancer treatment.
  • Understanding these interactions may lead to strategies to overcome RA resistance in cancer therapy.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...